Transfusion Medicine Reviews
Volume 22, Issue 3 , Pages 234-242 , July 2008

The In Vitro Bioassay Systems for the Amplification and Detection of Abnormal Prion PrPSc in Blood and Tissues

References 

  1. Farrugia A, Ironside JW, Giangrande P. Variant Creutzfeldt-Jakob disease transmission by plasma products: Assessing and communicating risk in an era of scientific uncertainty. Vox Sang. 2005;89:186–192
  2. Weissmann C, Aguzzi A. Approaches to therapy of prion diseases. Annu Rev Med. 2005;56:321–344
  3. Hewitt PE, Llewelyn CA, Mackenzie J, et al. Creutzfeldt-Jakob disease and blood transfusion: Results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang. 2006;91:221–230
  4. Mushahwar IK. Verses, viruses, and the vulnerability of the blood supply in industrialized countries. J Med Virol. 2007;79:1229–1237
  5. Castilla J, Saa P, Soto C. Detection of prions in blood. Nat Med. 2005;11:982–985
  6. Supattapone S, Geoghegan JC, Rees JR. On the horizon: A blood test for prions. Trends Microbiol. 2006;14:149–151
  7. Saa P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science. 2006;313:92–94
  8. Jones M, Peden A, Prowse C, et al. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrP(Sc). J Pathol. 2007;213:21–26
  9. Chang B, Cheng X, Yin S, et al. Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clin Vaccine Immunol. 2007;14:36–43
  10. Carp RI, Callahan SM, Patrick BA, et al. Interaction of scrapie agent and cells of the lymphoreticular system. Arch Virol. 1994;136:255–268
  11. Bosque PJ, Prusiner SB. Cultured cell sublines highly susceptible to prion infection. J Virol. 2000;74:4377–4386
  12. Aguzzi A, Heppner FL, Heikenwalder M, et al. Immune system and peripheral nerves in propagation of prions to CNS. Br Med Bull. 2003;66:141–159
  13. Archer F, Bachelin C, Andreoletti O, et al. Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J Virol. 2004;78:482–490
  14. de Almeida CJ, Chiarini LB, da Silva JP, et al. The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol. 2005;77:238–246
  15. Glatzel M, Abela E, Maissen M, et al. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med. 2004;349:1812–1820
  16. Saa P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem. 2006;281:35245–35252
  17. Soto C, Saborio GP, Anderes L. Cyclic amplification of protein misfolding: Application to prion-related disorders and beyond. Trends Neurosci. 2002;25:390–394
  18. Minor P, Newham J, Jones N, et al. Standards for the assay of Creutzfeldt-Jakob disease specimens. J Gen Virol. 2004;85:1777–1784(Pt 6)
  19. Health Protection Agency. 4th case of variant CJD infection associated with blood transfusion. http://www.hpa.org.uk/hpa/news/articles/press_releases/2007/070118_vCJD.htm.
  20. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004;63:417–421
  21. Sakudo A, Nakamura I, Ikuta K, et al. Recent developments in prion disease research: Diagnostic tools and in vitro cell culture models. J Vet Med Sci. 2007;69:329–337
  22. Lehto MT, Peery HE, Cashman NR. Current and future molecular diagnostics for prion diseases. Expert Rev Mol Diagn. 2006;6:597–611
  23. Castilla J, Saa P, Morales R, et al. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol. 2006;412:3–21
  24. Solassol J, Crozet C, Perrier V, et al. Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J Gen Virol. 2004;85:1791–1799(Pt 6)
  25. Ladogana A, Liu Q, Xi Y-G, et al. Proteinase-resistant protein in human neuroblastoma cells infected with brain material from Creutzfeld-Jakob patient. Lancet. 1995;345:594–595
  26. Arjona A, Simarro L, Islinger F, et al. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures. Proc Natl Acad Sci U S A. 2004;101:8768–8773
  27. Klohn PC, Stoltze L, Flechsig E, et al. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci U S A. 2003;100:11666–11671
  28. Baron GS, Magalhaes AC, Prado MA, et al. Mouse-adapted scrapie infection of SN56 cells: Greater efficiency with microsome-associated versus purified PrP-res. J Virol. 2006;80:2106–2117
  29. Raymond GJ, Olsen EA, Lee KS, et al. Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease. J Virol. 2006;80:596–604
  30. Solassol J, Crozet C, Lehmann S. Prion propagation in cultured cells. Br Med Bull. 2003;66:87–97
  31. Vorberg I, Raines A, Story B, et al. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J Infect Dis. 2004;189:431–439
  32. Butler DA, Scott MR, Bockman JM, et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol. 1988;62:1558–1564
  33. Blochberger TC, Cooper C, Peretz D, et al. Prion protein expression in Chinese hamster ovary cells using a glutamine synthetase selection and amplification system. Protein Eng. 1997;10:1465–1473
  34. Beranger F, Mange A, Solassol J, et al. Cell culture models of transmissible spongiform encephalopathies. Biochem Biophys Res Commun. 2001;289:311–316
  35. Nishida N, Katamine S, Manuelidis L. Reciprocal interference between specific CJD and scrapie agents in neural cell cultures. Science. 2005;310:493–496
  36. Lehmann S, Daude N, Harris DA. A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells. Brain Res Mol Brain Res. 1997;52:139–145
  37. Weissmann C. Birth of a prion: Spontaneous generation revisited. Cell. 2005;122:165–168
  38. Brandner S, Raeber A, Sailer A, et al. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci U S A. 1996;93:13148–13151
  39. Nishida N, Harris DA, Vilette D, et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol. 2001;74:320–325
  40. Satoh J, Yamamura T. Gene expression profile following stable expression of the cellular prion protein. Cell Mol Neurobiol. 2004;24:793–814
  41. Vilette D, Andreoletti O, Archer F, et al. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci U S A. 2001;98:4055–4059
  42. Laude H, Vilette D, Le Dur A, et al. New in vivo and ex vivo models for the experimental study of sheep scrapie: Development and perspectives. C R Biol. 2002;325:49–57
  43. Nunziante M, Gilch S, Schatzl HM. Prion diseases: From molecular biology to intervention strategies. Chembiochem. 2003;4:1268–1284
  44. Beringue V, Vilette D, Mallinson G, et al. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J Biol Chem. 2004;279:39671–39676
  45. Perrier V, Solassol J, Crozet C, et al. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J Neurochem. 2004;89:454–463
  46. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411:810–813
  47. Weber P, Giese A, Piening N, et al. Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc Natl Acad Sci U S A. 2006;103:15818–15823
  48. Weber P, Giese A, Piening N, et al. Generation of genuine prion infectivity by serial PMCA. Vet Microbiol. 2007;123:346–357
  49. Supattapone S. Prion protein conversion in vitro. J Mol Med. 2004;82:348–356
  50. Kurt TD, Perrott MR, Wilusz CJ, et al. Efficient in vitro amplification of chronic wasting disease PrPres. J Virol. 2007;81:9605–9608
  51. Murayama Y, Yoshioka M, Yokoyama T, et al. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci Lett. 2007;413:270–273
  52. Murayama Y, Yoshioka M, Horii H, et al. Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation. Biochem Biophys Res Commun. 2006;348:758–762
  53. Bieschke J, Weber P, Sarafoff N, et al. Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci U S A. 2004;101:12207–12211
  54. Nishina KA, Deleault NR, Mahal SP, et al. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry. 2006;45:14129–14139
  55. Deleault NR, Harris BT, Rees JR, et al. From the cover: Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A. 2007;104:9741–9746
  56. Safar J, Wille H, Itri V, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med. 1998;4:1157–1165
  57. Safar JG, Scott M, Monaghan J, et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol. 2002;20:1147–1150
  58. Safar JG, Geschwind MD, Deering C, et al. Diagnosis of human prion disease. Proc Natl Acad Sci U S A. 2005;102:3501–3506
  59. Bellon A, Seyfert-Brandt W, Lang W, et al. Improved conformation-dependent immunoassay: Suitability for human prion detection with enhanced sensitivity. J Gen Virol. 2003;84:1921–1925(Pt 7)
  60. Prusiner SB, Safar JG: Method of concentrating prion proteins in blood samples. US Patent #6166187 (2000).
  61. Paramithiotis E, Pinard M, Lawton T, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat Med. 2003;9:893–899
  62. Caughey B. Probing for prions: Recognizing misfolded PrP. Nat Med. 2003;9:819–820

PII: S0887-7963(08)00016-3

doi: 10.1016/j.tmrv.2008.02.004

Transfusion Medicine Reviews
Volume 22, Issue 3 , Pages 234-242 , July 2008

Article Tools